HIV-associated anal cancer

HIV-associated anal carcinoma, a non-AIDS-defining cancer, is a human papillomavirus-associated malignancy with a spectrum of preinvasive changes. The standardized incidence ratio for anal cancer in patients with HIV/AIDS is 20-50. Algorithms for anal cancer screening include anal cytology followed...

Descripción completa

Detalles Bibliográficos
Autores principales: Newsom-Davis, Thomas, Bower, Mark
Formato: Texto
Lenguaje:English
Publicado: Faculty of 1000 Ltd 2010
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3026623/
https://www.ncbi.nlm.nih.gov/pubmed/21283597
http://dx.doi.org/10.3410/M2-85
_version_ 1782197061554274304
author Newsom-Davis, Thomas
Bower, Mark
author_facet Newsom-Davis, Thomas
Bower, Mark
author_sort Newsom-Davis, Thomas
collection PubMed
description HIV-associated anal carcinoma, a non-AIDS-defining cancer, is a human papillomavirus-associated malignancy with a spectrum of preinvasive changes. The standardized incidence ratio for anal cancer in patients with HIV/AIDS is 20-50. Algorithms for anal cancer screening include anal cytology followed by high-resolution anoscopy for those with abnormal findings. Outpatient topical treatments for anal intraepithelial neoplasia include infrared coagulation therapy, trichloroacetic acid, and imiquimod. The development of cost-effective national screening programs for HIV-associated anal cancer remains a challenge.
format Text
id pubmed-3026623
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Faculty of 1000 Ltd
record_format MEDLINE/PubMed
spelling pubmed-30266232011-01-31 HIV-associated anal cancer Newsom-Davis, Thomas Bower, Mark F1000 Med Rep Review Article HIV-associated anal carcinoma, a non-AIDS-defining cancer, is a human papillomavirus-associated malignancy with a spectrum of preinvasive changes. The standardized incidence ratio for anal cancer in patients with HIV/AIDS is 20-50. Algorithms for anal cancer screening include anal cytology followed by high-resolution anoscopy for those with abnormal findings. Outpatient topical treatments for anal intraepithelial neoplasia include infrared coagulation therapy, trichloroacetic acid, and imiquimod. The development of cost-effective national screening programs for HIV-associated anal cancer remains a challenge. Faculty of 1000 Ltd 2010-12-08 /pmc/articles/PMC3026623/ /pubmed/21283597 http://dx.doi.org/10.3410/M2-85 Text en © 2010 Faculty of 1000 Ltd http://creativecommons.org/licenses/by-nc/3.0/legalcode This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use this work for commercial purposes
spellingShingle Review Article
Newsom-Davis, Thomas
Bower, Mark
HIV-associated anal cancer
title HIV-associated anal cancer
title_full HIV-associated anal cancer
title_fullStr HIV-associated anal cancer
title_full_unstemmed HIV-associated anal cancer
title_short HIV-associated anal cancer
title_sort hiv-associated anal cancer
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3026623/
https://www.ncbi.nlm.nih.gov/pubmed/21283597
http://dx.doi.org/10.3410/M2-85
work_keys_str_mv AT newsomdavisthomas hivassociatedanalcancer
AT bowermark hivassociatedanalcancer

Ejemplares similares